Important event

Multimodal Intelligence (02586) will be offering shares from November 28 to December 3, proposing a global issuance of 25.774 million shares.

Reshape Energy (02570) will be offering shares from November 28 to December 3, proposing a global issuance of approximately 4.8279 million shares.

Yuexiu Property (00123) won the bid for the Yangsi plot in Pudong, Shanghai, by a public listing method with 7.897 billion yuan.

Boc Aviation (02588) subsidiary is purchasing 14 Boeing 737-8 aircraft.

Akeso (09926): Hongtianyuan (Cadenos) and Yidafang (Ivoclar) have been included in the national medical insurance pharmaceutical catalog.

Ascentage Pharma-B (06855): The new indication for APL-101 has been included in the new National Medical Insurance Pharmaceutical Directory.

Luye Pharma-B (02105): The IND enabling study for LAE123 targeting severe therapy has been initiated.

Innovent Bio (01801): The new drug, Tyvyt (toripalimab injection), and the new indication for APL-101 (olarabine) have been included in the 2024 edition of the National Medical Insurance Pharmaceutical Directory.

Grandpharma (00512): The global innovative radiolabelled therapeutic drug TLX250-CDx has completed the first patient enrolment in the Phase III clinical study in China.

Hutchmed (China) (00013): The renewal of the current agreement for Savolitinib has been successfully completed in the National Medical Insurance Pharmaceutical Directory of China.

Simcere Pharma (02096): Ke Zu La, Enlituo, and Xian Bixin three innovative drugs included in the new version of the national medical insurance pharmaceutical catalog.

Repurchase/Shareholding

COSCO Shipping Holdings (01919) spent 26.3274 million Hong Kong dollars to repurchase 2.42 million shares on November 28.

Sinopec Corp (00386) spent approximately 28.1748 million Hong Kong dollars to repurchase 6.764 million shares on November 28.

Kuaishou-W (01024) spent HKD 29.4377 million to repurchase 0.62 million shares on November 28.

Alibaba-W (09988) spent 39.9911 million USD to repurchase 3.6796 million shares on November 27.

AIA (01299) spent 0.452 billion Hong Kong dollars to repurchase 7.807 million shares on November 28.

Tencent (00700) spent approximately 0.7 billion Hong Kong dollars to repurchase 1.75 million shares on November 28.

The controlling shareholder of Yankuang Energy (01171), Shandong Energy, has cumulatively increased shareholding by 27.71538 million shares, and the shareholding plan has been completed.

Livzon Pharma (01513) plans to repurchase a portion of its A-shares.

Operating Performance

Bosideng (03998) announced its interim performance, with profits attributable to equity shareholders increasing by 23% year-on-year to approximately 1.13 billion yuan, and a distribution of 6 Hong Kong cents per share.

For more details, please refer to the CITIC Securities website ().